Harbin Medisan Pharmaceutical Co., Ltd. (SHE:002900)

China flag China · Delayed Price · Currency is CNY
11.56
+0.01 (0.09%)
Apr 30, 2026, 3:04 PM CST
Market Cap3.58B +4.4%
Revenue (ttm)813.23M -25.4%
Net Income-317.84M
EPS-0.98
Shares Out309.54M
PE Ration/a
Forward PEn/a
Dividend0.20 (1.73%)
Ex-Dividend DateMay 29, 2025
Volume5,004,400
Average Volume8,426,835
Open10.68
Previous Close11.55
Day's Range10.68 - 11.76
52-Week Range10.48 - 17.86
Beta0.58
RSI51.36
Earnings DateApr 28, 2026

About SHE:002900

Harbin Medisan Pharmaceutical Co., Ltd. engages in the research, development, production, and sale chemical pharmaceutical preparations in China. The company offers various drugs for nervous system, cardiovascular system, systemic anti-infective, muscle and skeletal system, nutritional infusion, and body fluid balance infusion; and other products, including oxaliplatin for injection, calcium folinate for injection, hydroxylcamptothecine injection, tropisetron hydrochloride for injection, tropisetron hydrochloride and glucose injection, gabexate... [Read more]

Sector Healthcare
Founded 1996
Employees 2,522
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 002900
Full Company Profile

Financial Performance

Financial Statements